These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 28442423)
41. Polygenic transmission and complex neuro developmental network for attention deficit hyperactivity disorder: genome-wide association study of both common and rare variants. Yang L; Neale BM; Liu L; Lee SH; Wray NR; Ji N; Li H; Qian Q; Wang D; Li J; Faraone SV; Wang Y; Am J Med Genet B Neuropsychiatr Genet; 2013 Jul; 162B(5):419-430. PubMed ID: 23728934 [TBL] [Abstract][Full Text] [Related]
42. Case-control study of six genes asymmetrically expressed in the two cerebral hemispheres: association of BAIAP2 with attention-deficit/hyperactivity disorder. Ribasés M; Bosch R; Hervás A; Ramos-Quiroga JA; Sánchez-Mora C; Bielsa A; Gastaminza X; Guijarro-Domingo S; Nogueira M; Gómez-Barros N; Kreiker S; Gross-Lesch S; Jacob CP; Lesch KP; Reif A; Johansson S; Plessen KJ; Knappskog PM; Haavik J; Estivill X; Casas M; Bayés M; Cormand B Biol Psychiatry; 2009 Nov; 66(10):926-34. PubMed ID: 19733838 [TBL] [Abstract][Full Text] [Related]
43. The possible involvement of genetic variants of NET1 in the etiology of attention-deficit/hyperactivity disorder comorbid with oppositional defiant disorder. Liu L; Cheng J; Li H; Yang L; Qian Q; Wang Y J Child Psychol Psychiatry; 2015 Jan; 56(1):58-66. PubMed ID: 24942521 [TBL] [Abstract][Full Text] [Related]
44. Increased risk of attention-deficit/hyperactivity disorder associated with exposure to organophosphate pesticide in Taiwanese children. Yu CJ; Du JC; Chiou HC; Chung MY; Yang W; Chen YS; Fuh MR; Chien LC; Hwang B; Chen ML Andrology; 2016 Jul; 4(4):695-705. PubMed ID: 27070915 [TBL] [Abstract][Full Text] [Related]
45. Evidence of association between SNAP25 gene and attention deficit hyperactivity disorder in a Latin American sample. Gálvez JM; Forero DA; Fonseca DJ; Mateus HE; Talero-Gutierrez C; Velez-van-Meerbeke A Atten Defic Hyperact Disord; 2014 Mar; 6(1):19-23. PubMed ID: 24362847 [TBL] [Abstract][Full Text] [Related]
46. Case-control genome-wide association study of persistent attention-deficit hyperactivity disorder identifies FBXO33 as a novel susceptibility gene for the disorder. Sánchez-Mora C; Ramos-Quiroga JA; Bosch R; Corrales M; Garcia-Martínez I; Nogueira M; Pagerols M; Palomar G; Richarte V; Vidal R; Arias-Vasquez A; Bustamante M; Forns J; Gross-Lesch S; Guxens M; Hinney A; Hoogman M; Jacob C; Jacobsen KK; Kan CC; Kiemeney L; Kittel-Schneider S; Klein M; Onnink M; Rivero O; Zayats T; Buitelaar J; Faraone SV; Franke B; Haavik J; Johansson S; Lesch KP; Reif A; Sunyer J; Bayés M; Casas M; Cormand B; Ribasés M Neuropsychopharmacology; 2015 Mar; 40(4):915-26. PubMed ID: 25284319 [TBL] [Abstract][Full Text] [Related]
47. Further replication of the synergistic interaction between LPHN3 and the NTAD gene cluster on ADHD and its clinical course throughout adulthood. Kappel DB; Schuch JB; Rovaris DL; da Silva BS; Cupertino RB; Winkler C; Teche SP; Vitola ES; Karam RG; Rohde LA; Bau CHD; Grevet EH; Mota NR Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):120-127. PubMed ID: 28624582 [TBL] [Abstract][Full Text] [Related]
48. Brain Correlates of the Interaction Between 5-HTTLPR and Psychosocial Stress Mediating Attention Deficit Hyperactivity Disorder Severity. van der Meer D; Hoekstra PJ; Zwiers M; Mennes M; Schweren LJ; Franke B; Heslenfeld DJ; Oosterlaan J; Faraone SV; Buitelaar JK; Hartman CA Am J Psychiatry; 2015 Aug; 172(8):768-75. PubMed ID: 25998280 [TBL] [Abstract][Full Text] [Related]
49. Methylenetetrahydrofolate reductase gene polymorphisms in Turkish children with attention-deficit/hyperactivity disorder. Ergul E; Sazci A; Kara I Genet Test Mol Biomarkers; 2012 Jan; 16(1):67-9. PubMed ID: 21819229 [TBL] [Abstract][Full Text] [Related]
50. Partial replication of a DRD4 association in ADHD individuals using a statistically derived quantitative trait for ADHD in a family-based association test. Lasky-Su J; Banaschewski T; Buitelaar J; Franke B; Brookes K; Sonuga-Barke E; Ebstein R; Eisenberg J; Gill M; Manor I; Miranda A; Mulas F; Oades RD; Roeyers H; Rothenberger A; Sergeant J; Steinhausen HC; Taylor E; Zhou K; Thompson M; Asherson P; Faraone SV Biol Psychiatry; 2007 Nov; 62(9):985-90. PubMed ID: 17560555 [TBL] [Abstract][Full Text] [Related]
51. Rare DNA variants in the brain-derived neurotrophic factor gene increase risk for attention-deficit hyperactivity disorder: a next-generation sequencing study. Hawi Z; Cummins TD; Tong J; Arcos-Burgos M; Zhao Q; Matthews N; Newman DP; Johnson B; Vance A; Heussler HS; Levy F; Easteal S; Wray NR; Kenny E; Morris D; Kent L; Gill M; Bellgrove MA Mol Psychiatry; 2017 Apr; 22(4):580-584. PubMed ID: 27457811 [TBL] [Abstract][Full Text] [Related]
52. Dopaminergic haplotype as a predictor of spatial inattention in children with attention-deficit/hyperactivity disorder. Bellgrove MA; Johnson KA; Barry E; Mulligan A; Hawi Z; Gill M; Robertson I; Chambers CD Arch Gen Psychiatry; 2009 Oct; 66(10):1135-42. PubMed ID: 19805704 [TBL] [Abstract][Full Text] [Related]
53. Investigation of the G protein subunit Galphaolf gene (GNAL) in attention deficit/hyperactivity disorder. Laurin N; Ickowicz A; Pathare T; Malone M; Tannock R; Schachar R; Kennedy JL; Barr CL J Psychiatr Res; 2008 Jan; 42(2):117-24. PubMed ID: 17166517 [TBL] [Abstract][Full Text] [Related]
54. Low blood levels of lead and mercury and symptoms of attention deficit hyperactivity in children: a report of the children's health and environment research (CHEER). Ha M; Kwon HJ; Lim MH; Jee YK; Hong YC; Leem JH; Sakong J; Bae JM; Hong SJ; Roh YM; Jo SJ Neurotoxicology; 2009 Jan; 30(1):31-6. PubMed ID: 19100765 [TBL] [Abstract][Full Text] [Related]
55. KTN1 variants and risk for attention deficit hyperactivity disorder. Luo X; Guo X; Tan Y; Zhang Y; Garcia-Milian R; Wang Z; Shi J; Yu T; Ji J; Wang X; Xu J; Zhang H; Zuo L; Lu L; Wang K; Li CR Am J Med Genet B Neuropsychiatr Genet; 2020 Jun; 183(4):234-244. PubMed ID: 32190980 [TBL] [Abstract][Full Text] [Related]
56. Association between the group III metabotropic glutamate receptor gene polymorphisms and attention-deficit/hyperactivity disorder and functional exploration of risk loci. Zhang Q; Chen X; Li S; Yao T; Wu J J Psychiatr Res; 2021 Jan; 132():65-71. PubMed ID: 33068816 [TBL] [Abstract][Full Text] [Related]
57. [Combination of DRD4 and DAT1 genotypes is an important risk factor for attention deficit disorder with hyperactivity families living in Santiago, Chile]. Henríquez B H; Henríquez H M; Carrasco Ch X; Rothhammer A P; Llop R E; Aboitiz F; Rothhammer E F Rev Med Chil; 2008 Jun; 136(6):719-24. PubMed ID: 18769827 [TBL] [Abstract][Full Text] [Related]
58. Childhood Blood Lead Levels and Symptoms of Attention Deficit Hyperactivity Disorder (ADHD): A Cross-Sectional Study of Mexican Children. Huang S; Hu H; Sánchez BN; Peterson KE; Ettinger AS; Lamadrid-Figueroa H; Schnaas L; Mercado-García A; Wright RO; Basu N; Cantonwine DE; Hernández-Avila M; Téllez-Rojo MM Environ Health Perspect; 2016 Jun; 124(6):868-74. PubMed ID: 26645203 [TBL] [Abstract][Full Text] [Related]
59. Gene-wide Association Study Reveals RNF122 Ubiquitin Ligase as a Novel Susceptibility Gene for Attention Deficit Hyperactivity Disorder. Garcia-Martínez I; Sánchez-Mora C; Soler Artigas M; Rovira P; Pagerols M; Corrales M; Calvo-Sánchez E; Richarte V; Bustamante M; Sunyer J; Cormand B; Casas M; Ramos-Quiroga JA; Ribasés M Sci Rep; 2017 Jul; 7(1):5407. PubMed ID: 28710364 [TBL] [Abstract][Full Text] [Related]
60. Two SNAP-25 genetic variants in the binding site of multiple microRNAs and susceptibility of ADHD: A meta-analysis. Ye C; Hu Z; Wu E; Yang X; Buford UJ; Guo Z; Saveanu RV J Psychiatr Res; 2016 Oct; 81():56-62. PubMed ID: 27380186 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]